Almaaytah, A., & Elhajji, F. D. (2019). Comparative Cost Efficiency of the Originator Drug of Infliximab and its Biosimilar for the Treatment of Rheumatoid Arthritis in the MENA Region. International Journal of Pharmaceutical Investigation, 9(1), 12-15. Retrieved from http://jpionline.org/index.php/ijpi/article/view/311